维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Zielinski GD"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	HPV testing and monitoring of women after treatment of CIN 3:review of the literature and Meta-analysis显示文摘	Zielinski GD Bais AG Helmerhorst TJ	2004	Obstet Gynecol Surv2004，59，7：	1
	2	The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix显示文摘	Zielinski GD Snijders PJ Rozendaal L		0，，04：	1
	3	HPV testing and monitoringof women after treatment of CIN 3: review of the literature and metaanalysis显示文摘	Zielinski GD Bais AG Helmerhorst TJ	2004	Obstet Gynecol Surv2004，59，7：	1
	4	Benign adenoma of themiddle ear cavity causing facial paralysis 显示文摘	Zahtz GD Zielinski B Abramson AL	1981	Otolaryngol HeadNeck Surg1981，89，4：	1
	5	HPV testing and monitoring of women after treatment of CIN 3 : review of the literature and meta-analysis 显示文摘	Zielinski GD Bais AG Helmerhorst TJ	2004	Obstet Gynecol Surv2004，59，7：	1
	6	HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3 显示文摘	Zielinski GD Rozendaal L Voorhorst FJ	2003	Gynecol Oncol2003，91，1：	1
	7	The presence of high - risk HPV combined with specific P53 and P16^INK40 expression patterns points to high - risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix显示文摘	Zielinski GD Snijders PJ Rozendaal L	2003	J Pathol2003，201，4：	1
	8	HPV testing and monitoring of women after treatment of CIN3:review of the literature and meta-analysis显示文摘	Zielinski GD Bais AG Helmerhorst TJ	2004	Obstet Gynecol Surv2004，59，7：	1
	9	HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears 显示文摘	Zielinski GD Snijders PJ Rozendaal L	2001	Br J Cancer2001，85，3：	1
	10	HPV testing can reduce the number of follow-up visit in women treated for cervical intraepithelial neoplasis grade 3 显示文摘	Zielinski GD Rozendaal L Voorhorst FJ	2003	Gynecol Oncol2003，91，1：	1
	11	Evaluation of cervical screening strategies with adjunct high - risk human papillomavirus testing for women with borderline or mild dyskaryosis 显示文摘	Berkhof J Bruijne MC Zielinski GD	2006	Int J Cancer2006，118，7：	1
	12	The combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix 显示文摘	Zielinski GD Snijders PJ presence of high-risk HPV Rozendaal L	2003	J Pathol2003，201，：	1
	13	HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears 显示文摘	Zielinski GD Snijders PJ Rozendaal L	2001	Br J Cancer2001，85，：	1
	14	HPV testing and monitoring of women after treatment of CIN3 : review of the literature and meta-analysis显示文摘	Zielinski GD Bais AG Helmerhorst TJ	2004	Obstet Gynecol Surv2004，59，：	1
	15	Clinical relevance of human papillomavirus testing in cytopathology显示文摘	Brink AA Zielinski GD Steenbergen RD	2005	Cytopathology2005，16，：	1
	16	High-risk HPV testing in women with borderline and mild dyskaryosis:Iongterm follow up data and clinical relevance显示文摘	Snijers PJ Rozendaal L	2001	J Pathol2001，195，：	1
	17	The presence of high-risk HPV combined with specific p53 and p16INK4A expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix显示文摘	Zielinski GD Snijders PJ Rozendaal L	2003	J Pathol2003，201，53：	1
	18	HPV testing can reduce the number of follow-up visits in women treated for cervi- cal intraepithelial neoplasia grade 3 显示文摘	Zielinski GD Rozendaal L Voorhorst FJ	2002	Gynecol Oncol2002，91，1：	1
	19	HPV testing can reduce the number of follow-up visits in woman treated for cervical intraepithelial neoplasia grade 3显示文摘	Zielinski GD Rozendaal L Voorhorst FJ	2003	Gynecol Oncol2003，91，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费